John D. Hainsworth
Sarah Cannon Research Institute
Nashville
TN 37203
USA
Name/email consistency: high
- Molecular gene expression profiling to predict the tissue of origin and direct site-specific therapy in patients with carcinoma of unknown primary site: a prospective trial of the Sarah Cannon research institute. Hainsworth, J.D., Rubin, M.S., Spigel, D.R., Boccia, R.V., Raby, S., Quinn, R., Greco, F.A. J. Clin. Oncol. (2013)
- Brief-duration rituximab/chemotherapy followed by maintenance rituximab in patients with diffuse large B-cell lymphoma who are poor candidates for R-CHOP chemotherapy: a phase II trial of the Sarah Cannon Oncology Research Consortium. Hainsworth, J.D., Flinn, I.W., Spigel, D.R., Clark, B.L., Griner, P.L., Vazquez, E.R., Doss, H.H., Shipley, D., Franco, L.A., Burris, H.A., Greco, F.A. Clin. Lymphoma. Myeloma. Leuk (2010)
- Oxaliplatin and capecitabine in the treatment of patients with recurrent or refractory carcinoma of unknown primary site: a phase 2 trial of the Sarah Cannon Oncology Research Consortium. Hainsworth, J.D., Spigel, D.R., Burris, H.A., Shipley, D., Farley, C., Macias-Perez, I.M., Barton, J., Greco, F.A. Cancer (2010)
- Paclitaxel/carboplatin/etoposide versus gemcitabine/irinotecan in the first-line treatment of patients with carcinoma of unknown primary site: a randomized, phase III Sarah Cannon Oncology Research Consortium Trial. Hainsworth, J.D., Spigel, D.R., Clark, B.L., Shipley, D., Thompson, D.S., Farley, C., West-Osterfield, K., Lane, C.M., Cescon, T., Bury, M.J., Greco, F.A. Cancer. J (2010)
- Bevacizumab and everolimus in the treatment of patients with metastatic melanoma: a phase 2 trial of the Sarah Cannon Oncology Research Consortium. Hainsworth, J.D., Infante, J.R., Spigel, D.R., Peyton, J.D., Thompson, D.S., Lane, C.M., Clark, B.L., Rubin, M.S., Trent, D.F., Burris, H.A. Cancer (2010)
- Concurrent radiotherapy and temozolomide followed by temozolomide and sorafenib in the first-line treatment of patients with glioblastoma multiforme. Hainsworth, J.D., Ervin, T., Friedman, E., Priego, V., Murphy, P.B., Clark, B.L., Lamar, R.E. Cancer (2010)
- Phase II trial of bevacizumab and everolimus in patients with advanced renal cell carcinoma. Hainsworth, J.D., Spigel, D.R., Burris, H.A., Waterhouse, D., Clark, B.L., Whorf, R. J. Clin. Oncol. (2010)
- A phase II, open-label, randomized study to assess the efficacy and safety of AZD6244 (ARRY-142886) versus pemetrexed in patients with non-small cell lung cancer who have failed one or two prior chemotherapeutic regimens. Hainsworth, J.D., Cebotaru, C.L., Kanarev, V., Ciuleanu, T.E., Damyanov, D., Stella, P., Ganchev, H., Pover, G., Morris, C., Tzekova, V. J. Thorac. Oncol (2010)
- Rituximab plus short-duration chemotherapy followed by Yttrium-90 Ibritumomab tiuxetan as first-line treatment for patients with follicular non-Hodgkin lymphoma: a phase II trial of the Sarah Cannon Oncology Research Consortium. Hainsworth, J.D., Spigel, D.R., Markus, T.M., Shipley, D., Thompson, D., Rotman, R., Dannaher, C., Greco, F.A. Clin. Lymphoma. Myeloma (2009)
- Paclitaxel/carboplatin plus bevacizumab/erlotinib in the first-line treatment of patients with carcinoma of unknown primary site. Hainsworth, J.D., Spigel, D.R., Thompson, D.S., Murphy, P.B., Lane, C.M., Waterhouse, D.M., Naot, Y., Greco, F.A. Oncologist (2009)
- Neoadjuvant chemotherapy/gefitinib followed by concurrent chemotherapy/radiation therapy/gefitinib for patients with locally advanced squamous carcinoma of the head and neck. Hainsworth, J.D., Spigel, D.R., Burris, H.A., Markus, T.M., Shipley, D., Kuzur, M., Lunin, S., Greco, F.A. Cancer (2009)
- Treatment for patients with unknown primary cancer and favorable prognostic factors. Hainsworth, J.D., Fizazi, K. Semin. Oncol. (2009)
- Combination therapy with fludarabine and rituximab followed by alemtuzumab in the first-line treatment of patients with chronic lymphocytic leukemia or small lymphocytic lymphoma: a phase 2 trial of the Minnie Pearl Cancer Research Network. Hainsworth, J.D., Vazquez, E.R., Spigel, D.R., Raefsky, E., Bearden, J.D., Saez, R.A., Greco, F.A. Cancer (2008)
- Weekly treatment with bortezomib for patients with recurrent or refractory multiple myeloma: a phase 2 trial of the Minnie Pearl Cancer Research Network. Hainsworth, J.D., Spigel, D.R., Barton, J., Farley, C., Schreeder, M., Hon, J., Greco, F.A. Cancer (2008)
- Phase II trial of bevacizumab and erlotinib in carcinomas of unknown primary site: the Minnie Pearl Cancer Research Network. Hainsworth, J.D., Spigel, D.R., Farley, C., Thompson, D.S., Shipley, D.L., Greco, F.A. J. Clin. Oncol. (2007)
- Weekly docetaxel and bortezomib as first-line treatment for patients with hormone-refractory prostate cancer: a Minnie Pearl Cancer Research Network phase II trial. Hainsworth, J.D., Meluch, A.A., Spigel, D.R., Barton, J., Simons, L., Meng, C., Gould, B., Greco, F.A. Clin. Genitourin. Cancer (2007)
- Weekly docetaxel versus docetaxel/gemcitabine in the treatment of elderly or poor performance status patients with advanced nonsmall cell lung cancer: a randomized phase 3 trial of the Minnie Pearl Cancer Research Network. Hainsworth, J.D., Spigel, D.R., Farley, C., Shipley, D.L., Bearden, J.D., Gandhi, J., Ann Houston, G., Anthony Greco, F. Cancer (2007)
- Treatment of advanced renal cell carcinoma with the combination bevacizumab/erlotinib/imatinib: a phase I/II trial. Hainsworth, J.D., Spigel, D.R., Sosman, J.A., Burris, H.A., Farley, C., Cucullu, H., Yost, K., Hart, L.L., Sylvester, L., Waterhouse, D.M., Greco, F.A. Clin. Genitourin. Cancer (2007)
- Weekly docetaxel/estramustine phosphate in patients with increasing serum prostate- specific antigen levels after primary treatment for prostate cancer: a phase II trial of the Minnie Pearl Cancer Research Network. Hainsworth, J.D., Meluch, A.A., Spigel, D.R., Yost, K., Meng, C., Greco, F.A. Clinical. Genitourinary. Cancer (2006)
- Phase II trial of paclitaxel, carboplatin, and etoposide in advanced poorly differentiated neuroendocrine carcinoma: a Minnie Pearl Cancer Research Network Study. Hainsworth, J.D., Spigel, D.R., Litchy, S., Greco, F.A. J. Clin. Oncol. (2006)
- Docetaxel and epirubicin as first-line treatment for patients with metastatic breast cancer: a Minnie Pearl Cancer Research Network Phase II trial. Hainsworth, J.D., Yardley, D.A., Spigel, D.R., Meluch, A.A., Rinaldi, D., Schnell, F.M., Greco, F.A. Cancer Invest. (2006)
- Rituximab plus short-duration chemotherapy as first-line treatment for follicular non-Hodgkin's lymphoma: a phase II trial of the minnie pearl cancer research network. Hainsworth, J.D., Litchy, S., Morrissey, L.H., Andrews, M.B., Grimaldi, M., McCarty, M., Greco, F.A. J. Clin. Oncol. (2005)
- Maximizing therapeutic benefit of rituximab: maintenance therapy versus re-treatment at progression in patients with indolent non-Hodgkin's lymphoma--a randomized phase II trial of the Minnie Pearl Cancer Research Network. Hainsworth, J.D., Litchy, S., Shaffer, D.W., Lackey, V.L., Grimaldi, M., Greco, F.A. J. Clin. Oncol. (2005)
- Paclitaxel, carboplatin, and oral etoposide as initial treatment for advanced ovarian carcinoma: a Minnie Pearl Cancer Research Network phase II trial. Hainsworth, J.D., Kalman, L., Castine, M., Sylvester, L., Greco, F.A. Gynecol. Oncol. (2005)
- Paclitaxel, carboplatin, and gemcitabine in the treatment of patients with advanced transitional cell carcinoma of the urothelium. Hainsworth, J.D., Meluch, A.A., Litchy, S., Schnell, F.M., Bearden, J.D., Yost, K., Greco, F.A. Cancer (2005)
- Combination chemotherapy with gemcitabine and irinotecan in patients with previously treated carcinoma of an unknown primary site: a Minnie Pearl Cancer Research Network Phase II trial. Hainsworth, J.D., Spigel, D.R., Raefsky, E.L., Kuzur, M.E., Yost, K., Kommor, M., Litchy, S., Greco, F.A. Cancer (2005)
- Treatment of metastatic renal cell carcinoma with a combination of bevacizumab and erlotinib. Hainsworth, J.D., Sosman, J.A., Spigel, D.R., Edwards, D.L., Baughman, C., Greco, A. J. Clin. Oncol. (2005)
- Weekly combination chemotherapy with docetaxel and gemcitabine as first-line treatment for elderly patients and patients with poor performance status who have extensive-stage small cell lung carcinoma: a Minnie Pearl Cancer Research Network phase II trial. Hainsworth, J.D., Carrell, D., Drengler, R.L., Scroggin, C., Greco, F.A. Cancer (2004)
- A phase II trial of preoperative concurrent radiation therapy and weekly paclitaxel/carboplatin for patients with locally advanced non-small-cell lung cancer. Hainsworth, J.D., Gray, J.R., Litchy, S., Bearden, J.D., Shaffer, D.W., Houston, G.A., Greco, F.A. Clin. Lung. Cancer (2004)
- Practical aspects of weekly docetaxel administration schedules. Hainsworth, J.D. Oncologist (2004)
- Single-agent rituximab as first-line and maintenance treatment for patients with chronic lymphocytic leukemia or small lymphocytic lymphoma: a phase II trial of the Minnie Pearl Cancer Research Network. Hainsworth, J.D., Litchy, S., Barton, J.H., Houston, G.A., Hermann, R.C., Bradof, J.E., Greco, F.A. J. Clin. Oncol. (2003)
- Combination chemotherapy with gemcitabine and vinorelbine in the treatment of patients with relapsed or refractory small cell lung cancer: a phase II trial of the Minnie Pearl Cancer Research Network. Hainsworth, J.D., Burris, H.A., Erland, J.B., Baker, M., Scullin, D.C., Shaffer, D.W., Greco, F.A. Cancer Invest. (2003)
- First-line treatment with brief-duration chemotherapy plus rituximab in elderly patients with intermediate-grade non-Hodgkin's lymphoma: phase II trial. Hainsworth, J.D., Litchy, S., Lamb, M.R., Rodriguez, G.I., Scroggin, C., Greco, F.A. Clin. Lymphoma (2003)
- A review of phase II studies of ZD9331 treatment for relapsed or refractory solid tumours. Hainsworth, J., Vergote, I., Janssens, J. Anticancer. Drugs (2003)
- Combination treatment with weekly docetaxel and gemcitabine for advanced non-small-cell lung cancer in elderly patients and patients with poor performance status: results of a Minnie Pearl Cancer Research Network phase II trial. Hainsworth, J.D., Erland, J.B., Barton, J.H., Thompson, D.S., Stagg, M.P., Bradof, J.E., Twele, T.W., Greco, E.A. Clin. Lung. Cancer (2003)
- Gefitinib in the treatment of advanced, refractory non-small-cell lung cancer: results in 124 patients. Hainsworth, J.D., Mainwaring, M.G., Thomas, M., Porter, L.L., Gian, V.G., Jones, S.F., Greco, F.A. Clin. Lung. Cancer (2003)
- Safety of rituximab in the treatment of B cell malignancies: implications for rheumatoid arthritis. Hainsworth, J.D. Arthritis Res. Ther. (2003)
- Paclitaxel, carboplatin, and topotecan in the treatment of patients with small cell lung cancer: a phase II trial of the Minnie Pearl Cancer Research Network. Hainsworth, J.D., Morrissey, L.H., Scullin, D.C., Houston, G.A., Prasthofer, E.F., Gray, J.R., Burris, H.A., Greco, F.A. Cancer (2002)
- Rituximab as first-line and maintenance therapy for patients with indolent non-hodgkin's lymphoma. Hainsworth, J.D., Litchy, S., Burris, H.A., Scullin, D.C., Corso, S.W., Yardley, D.A., Morrissey, L., Greco, F.A. J. Clin. Oncol. (2002)
- Paclitaxel and mitoxantrone in the treatment of metastatic breast cancer: a phase II trial of the Minnie Pearl Cancer Research Network. Hainsworth, J.D., Calvert, S., Greco, F.A. Cancer Invest. (2002)
- Diagnosis, staging, and clinical characteristics of the patient with mediastinal germ cell carcinoma. Hainsworth, J.D. Chest Surg. Clin. N. Am. (2002)
- The role of weekly docetaxel in the treatment of advanced non-small-cell lung cancer. Hainsworth, J.D., Greco, F.A. Clin. Lung. Cancer (2002)
- Gemcitabine in the second-line therapy of patients with carcinoma of unknown primary site: a phase II trial of the Minnie Pearl Cancer Research Network. Hainsworth, J.D., Burris, H.A., Calvert, S.W., Willcutt, N.T., Scullin, D.C., Bramham, J., Greco, F.A. Cancer Invest. (2001)
- Weekly docetaxel in the treatment of elderly patients with advanced breast cancer: a Minnie Pearl Cancer Research Network phase II trial. Hainsworth, J.D., Burris, H.A., Yardley, D.A., Bradof, J.E., Grimaldi, M., Kalman, L.A., Sullivan, T., Baker, M., Erland, J.B., Greco, F.A. J. Clin. Oncol. (2001)
- Weekly docetaxel with either gemcitabine or vinorelbine as second-line treatment in patients with advanced nonsmall cell lung carcinoma: Phase II trials of the Minnie Pearl Cancer Research Network. Hainsworth, J.D., Burris, H.A., Billings, F.T., Bradof, J.E., Baker, M., Greco, F.A. Cancer (2001)
